New Delhi: Cancer patients undergoingradiation therapy will now be able to escape its side effectswith the Defence Research and Development Organisationclaiming that it has developed a medicine to counter them. After a 15-year research, the DRDO has developed themedicine -- 2-Deoxy-D-glucose. The new drug has got clearancefrom the Drug Controller General of India. "The product is slated to hit the markets in the nextthree months," DRDO scientist and chief controller, LifeSciences, Dr W Selvamurthy said.
"This medicine will help reduce the dosage ofradiation to be given to the cancer patient, since it ensuresthat only the cancer cells are destroyed and the normal one`sare protected during therapy, which ultimately relieves thepatients from the side effects of the therapy," Selvamurtysaid. PTI
Exercise ‘causes asthma in athletes’
`Repressive drug policies boosting AIDS spread`